Peptic ulcer diseases. Perspectives on pathophysiology and therapy

Area of Science:

• Gastroenterology
• Cell Biology
• Pharmacology

Background:

• Peptic ulcers involve acid/peptic activity, but only a third of patients have increased acid secretion.
• Ulcers represent a focal disturbance in mucosal defense, not solely an acid problem.
• Mucosal defense mechanisms, like mucus and blood flow, are influenced by prostaglandins.

Purpose of the Study:

• To investigate the role of prostaglandins in peptic ulcer healing.
• To understand why prostaglandin-based therapies may not be curative.
• To explore factors impairing mucosal defense in ulcer patients.

Main Methods:

• Review of existing literature on peptic ulcer pathophysiology and prostaglandin function.
• Analysis of clinical observations regarding ulcer healing and recurrence rates.
• Hypothetical modeling of prostaglandin effects on damaged vs. healthy mucosa.

Main Results:

• Adequate acid inhibition promotes ulcer healing, but recurrence is common after therapy cessation.
• Synthetic prostaglandins show healing effectiveness linked to their antisecretory, not direct mucosal defense, potential.
• Prostaglandins may fail to enhance healing in ulcers because their targets are disrupted near the ulcer site.

Conclusions:

• Prostaglandin modulation of mucosal defense may not be a critical factor in human peptic ulcer healing.
• Impaired mucosal defense can result from prostaglandin inhibition (e.g., NSAIDs) or Campylobacter pylori infection.
• Ulcer healing is complex, involving both acid control and the integrity of local mucosal defenses.